Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only requiring two drops of blood, announced Wednesday that it had raised $71 million in a Series D funding ...
Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued YSI ...
The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it ...
Once outside the body, stored blood begins degrading until, by day 42, they're no longer usable. Until now, assessing its quality has required laborious microscopic examination by human experts. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results